Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: Possible involvement in cancer-associated immunosuppression mechanism

Oncology Reports

Volumn 8, Issue 3, 2001, Pages 649-653

  Yamaguchi, Yoshiyuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Immunosuppression; Lymphokine activated killer cells; Telomerase; Telomere

Indexed keywords

INTERLEUKIN 10; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA;

AGED; ARTICLE; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOKINE ACTIVATED KILLER CELL; MALE; METABOLISM; MIDDLE AGED; NEOPLASM; TELOMERE;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NEOPLASMS; TELOMERASE; TELOMERE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035346936     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Pardue ML and de Baryshe PG: Telomeres and telomerase: more than the end of the line. Chromosoma 108: 73-82, 1999.
2. Urquidi V, Tarin D and Goodison S: Telomerase in cancer: clinical applications. Ann Med 30: 419-430, 1998.